Bluebird Bio Inc. sell StockNews.com
Start price
05.10.24
/
50%
€0.49
Target price
05.10.25
-
Performance (%)
-25.94%
End price
06.10.25
-
Summary
This prediction is currently being closed. The prediction for Bluebird Bio Inc. shows a convincing performance of -25.94%. StockNews_com has a follow-up prediction for Bluebird Bio Inc. where he still thinks Bluebird Bio Inc. is a Sell. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bluebird Bio Inc. | - | - | - |
| iShares Core DAX® | 1.644% | 4.865% | 25.089% |
| iShares Nasdaq 100 | 0.747% | 2.923% | 8.975% |
| iShares Nikkei 225® | 2.442% | 6.212% | 21.408% |
| iShares S&P 500 | 0.618% | 2.843% | 5.726% |
Comments by StockNews_com for this prediction
In the thread Bluebird Bio Inc. diskutieren
bluebird bio, Inc. (NASDAQ: BLUE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLUE provided by MarketBeat
In the thread Trading Bluebird Bio Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten

